Acquiring Stenotrophomonas maltophilia does not reduce survival in patients with cystic fibrosis

Pediatric Pulmonology

Volumn 30, Issue SUPPL. 20, 2000, Pages 101-102

  Goss, C H ^a   Aitken, M L ^a   Otto, K ^a   Rubenfeld, G D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001114072     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Bauernfeind A, Emminger G, Horl G, Lorbeer B, Przyklenk B, Weisslein-Pfister C. Selective pressure of antistaphylococcal chemotherapeutics in favour of Pseudomonas aeruginosa in cystic fibrosis. Infection 1987;15:469-70.
2. Denton M, Todd NJ, Littlewood JM. Role of antipseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996;15:402-5.
3. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27:158-63.
4. Gladman G, Connor PJ, Williams RF, David TJ. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child 1992;67:192-5.
5. Karpati F, Malmborg AS, Alfredsson H, Hjelte L, Strandvik B. Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population. Infection 1994;22:258-63.
6. Demko CA, Stern RC, Doershuk CF. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr Pulmonol 1998;25:304-8.